Griffith’s Institute for Glycomics and Germany’s Bremen University have received funding to continue a research exchange to develop a drug delivery system to treat Non-Hodgkin’s Lymphoma.
Griffith University and University of Bremen researchers are at the helm of a discovery which could lead to a powerful and precise treatment for non-Hodgkin’s Lymphoma, one of the ten most common cancers in the world. Non-Hodgkin’s Lymphoma is a type of blood cancer involving the lymphatic system. “Although chemotherapies are available to treat non-Hodgkin’s […]
Griffith research finds genetic clues to understanding non-Hodgkin Lymphoma.